Biomarks of Resistance to Cetuximab in Colorectal Cancer

ABSTRACT: Interventions: A group:Before using cetuximab;B group:After progression of disease:no Primary outcome(s): KRAS gene sequence;NRAS gene sequence;BRAF gene sequence;PIK3CA gene sequence;EGFR gene sequence;EGFR gene copy numbers;EGFR expression;Her2 expression;c-Met expression;PTEN expression Study Design: historical control

DISEASE(S): Colorectal Cancer

PROVIDER: 2671639 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR